Lactate dehydrogenase-elevating virus: an ideal persistent virus?
Tóm tắt
LDV contradicts all commonly held views about mechanisms of virus persistence, namely that persistence is primarily associated with noncytopathic viruses, or the selection of immune escape variants or other mutants, or a decrease in expression of certain viral proteins by infected cells, or replication in “immune-privileged sites”, or a general suppression of the host immune system, etc. [1, 2, 5, 54, 77, 78]. LDV is a highly cytocidal virus that invariably establishes a life-long, viremic, persistence in mice, in spite of normal anti-viral immune responses. One secret of LDV's success in persistence is its specificity for a renewable, nonessential population of cells that is continuously regenerated, namely a subpopulation of macrophages. Since the continuous destruction of these cells is not associated with any obvious health effects, this macrophage population seems nonessential to the well-being of its host. The only function identified for this subpopulation of macrophages is clearance of the muscle type of LDH and some other enzymes [59, 67, 68]. Furthermore, the effects of LDV infection on the host immune system, namely the polyclonal activation of B cells and its associated production of autoantibodies, and the slight impairment of primary and secondary antibody responses also do not seem to be severe enough to cause any clinical consequences. But how does LDV replication in macrophages escape all host defenses? Persistence is not dependent on the seletion of immune escape variants or other mutants ([58] and Palmer, Even and Plagemann, unpublished results). Also, LDV replication is not restricted to immune-privileged sites [5]. LDV replication persists in the liver, lymphoidal tissues and testis [66]. Only the latter could be considered a site not readily accessible to immune surveillance. Most likely, resistance of LDV replication to antiviral immune responses is related to the unique structure of its envelope proteins and the production of large quantities of viral antigens. High titers of anti-LDV antibodies are generated in infected mice but they neutralize LDV infectivity only very inefficiently and, even though the antiviral antibodies are mainly of the IgG2a and IgG2b isotypes, they do not mediate complement lyses of virions [31]. Interaction of the antibodies and complement with the VP-3/VP-2 heterodimers in the viral envelope may be impeded by the exposure of only very short peptide segments of these proteins at the envelope surface and the presence of large oligosaccharide side chains. Furthermore, since LDV maturation is restricted to intracytoplasmic cisternae [59, 71], the question arises of whether any of the viral proteins are available on the surface of infected cells for ADCC. CTLs also fail to control LDV replication. Altough CTLs specific for N/VP-1 are rapidly generated, these have disappeared by 30 days p.i. [26]. The reasons for this loss are unknown, but high-dose clonal exhaustion [41, 51, 77, 78] is a reasonable possibility since, regardless of the infectious dose, large amounts of LDV proteins are present in all the lymphoidal tissues at the time of the induction of the CTL response. Furthermore, after exhaustion of CTLs in the periphery, continuous replication of LDV in the thymus [65] assures that the mice become permanently immunologically tolerant with respect to LDV antigen-specific CTLs as a result of negative selection in the thymus. LDV might be a primary example for the effectiveness of a permanent clonal CTL deletion in adult animals under natural conditions of infection. The presumed modes of transmission of LDV in nature and the events associated with its infection of mice are strikingly similar to those observed during the acute and asymptomatic phases of infection with human immunodeficiency virus (HIV) [24, 29, 74, 78]. These include: (1) primary inefficient transmission via sexual and transplacental routes but effective transmission via blood; (2) primary replication in renewable populations of lymphoidal cells with production of large amounts of virus after the initial infection of the host followed by persistent low level of viremia in spite of antiviral immune responses; (3) persistence, reflecting continuous rounds of productive, cytocidal infection of permissive cells [59, 74] and the rate of generation of permissive cells which may be the main factor in determining the level of virus production (in the case of HIV, the rate of activation of CD4+ T cells to support a productive HIV replication might be the factor determining the rate of virus production and the progression of the disease); (4) rapid antibody formation but delayed production of neutralizing antibodies with limited neutralizing capacity; (5) rapid but transient generation of virus-specific CTLs; and (6) accumulation of large amounts of virus in newly formed germinal centers in the spleen and lymph nodes concomitant with an initiation of a permanent polyclonal activation of B cells resulting in an elevation of plasma IgG2a. The events described under points 2–6 might be generally associated with natural viremic persistent virus infections. Such persistent viruses, by necessity, have evolved properties that allow them to escape all host defenses and control of their infection by immunological processes is, therefore, difficult, if not impossible. Prevention of infection and chemotherapy may be the only approaches available to combat such virus infections.
Tài liệu tham khảo
Allen PM, Zinkernagel RM (1994) Promethean viruses. Nature 369:355
Ahmed R, Stevens JG (1990) Viral persistence. In: Fields BN, Knipe DM (eds) Virology. Raven Press, New York, pp 241–265
Anderson GW, Palmer GA, Rowland RRR, Even C, Plagemann PGW (1995) Infection of CNS cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol 69:308
Anderson GW, Palmer GA, Rowland RRR, Even C, Plagemann PGW (1995) Lactate dehydrogenaseelevating virus entry into the central nervous system and replication in anterior horn neurons. J Gen Virol 76:581
Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV (1994) CTL access to tissue antigen is restricted in vivo. J Immunol 153:482
Balasuriya UBR, Rossitto PV, DeMaula CD, MacLachlan NJ (1993) A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. J Gen Virol 74:2525
Brinton MA (1986) Lactate dehydrogenase-elevating virus. In: Bhatt RO, Jacoby RO, Morse HC, Nar AE (eds) Viral and mycoplasma infections of laboratory rodents. Academic Press. San Diego, pp 389–420
Brinton-Darnell M, Plagemann PGW (1975) Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus. J Virol 16:420
Buxton IK, Chan SPK, Plagemann PGW (1988) The Ia antigen is not the major receptor for lactate dehydrogenase-elevating virus on macrophages from CBA and BALB/c mice. Virus Res 9:205
Cafruny WA, Hovinen D (1988) Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies. J Gen Virol 69:723
Cafruny WA, Hovinen DE (1988) The relationship between route of infection and minimum infectious dose: studies with lactate dehydrogenase-elevating virus. J Virol Methods 20:265
Cafruny WA, Chan SPK, Harty JT, Yousefi S, Kowalchyk K, McDonald D, Foreman B, Budweg G, Plagemann PGW (1986) Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res 5:357
Chen Z, Faaberg KS, Plagemann PGW (1994) Detection of negative-stranded subgenomic RNAs but not of free leader in LDV-infected macrophages. Virus Res 34:167
Chen Z, Kuo L, Rowland RRR, Even C, Faaberg KS, Plagemann PGW (1993) Sequence of 3′-end of genome and of 5′-end of ORF 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5′-leader and bodies of seven subgenomic mRNAs. J Gen Virol 74:643
Chen Z, Faaberg KS, Plagemann PGW (1994) Determination of the 5′ end of the lactate dehydrogenaseelevating virus genome by two independent approaches. J Gen Virol 75:925
Coutelier JP, Snick J van (1985) Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol 15:250
Coutelier JP, Snick J van (1988) Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. J Gen Virol 69:2097
Coutelier JP, Coulie PG, Wauters P, Heremans H, Logt JTM van der (1990) In vivo polyclonal Blymphocyte activation elicited by murine viruses. J Virol 64:5383
Den Boon JA, Faaberg KS, Meulenberg JJM, Wassenaar ALM, Plagemann PGW, Gorbalenya AE, Snijder EJ (1995) Processing and evolution of the N-terminal region of the arterivirus replicase ORF 1a protein: identification of a second papainlike cysteine protease. J Virol 69:4500
Den Boon J, Snijder EJ, Chirnside ED, de Vries AAF, Horzinek ME, Spaan WJM (1991) Equine arteritis virus is not a togavirus but belongs to a coronavirus-like superfamily. J Virol 65:2910
Deregt D, de Vries AAF, Raamsman MJB, Elmgren LO, Rottier PJM (1994) Monoclonal antibodies to equine arteritis virus proteins identify the large envelope glycoprotein (gl) as a target for virus neutralization. J Gen Virol 75:2439
De Vries AAF, Chirnside ED, Horzinek MC, Rottier PJM (1992) Structural proteins of equine arteritis virus. J Virol 66:6294
De Vries, AAF, Raamsman MJB, Horzinek MC, Rottier PJM (1995) The small envelope glycoprotein (GS) of equine arteritis virus folds into three distinct monomers and a disulfide linked dimer. J Virol 69:3441
Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359
Even C, Plagemann PGW (1995) Pseudotype virions formed between mouse hepatitis virus and lactate dehydrogenase-elevating virus (LDV) mediate LDV replication in cells resistant to infection by LDV virions. J Virol 69:4237
Even C, Rowland RRR, Plagemann PGW (1995) Cytotoxic T cells are elicited during acute infection of mice by lactate dehydrogenase-elevating virus-infected mice but disappear during the chronic phase of infection. J Virol (in press)
Faaberg KS, Plagemann PGW (1995) The envelope proteins of lactate dehydrogenase-elevating virus and their conformation in membranes. Virology (in press)
Faaberg KS, Even C, Palmer GA, Plagemann PGW (1995) Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for virus infectivity. J Virol 69:613
Fauci AS (1993) Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011
Godeny EK, Chen L, Kumar SN, Methven SL, Koonin EV, Brinton MA (1993) Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV). Virology 194:585
Harty JT, Plagemann PGW (1988) Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection. J Virol 62:3210
Harty JT, Plagemann PGW (1990) Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus. J Virol 64:6257
Heremans H, Billiau A, Coutelier JP, DeSomer P (1987) The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon. Proc Soc Exp Biol Med 185:6
Horzinek MC (1981) Non-arthropod-borne togaviruses. Academic Press, London
Howard RJ, Notkins AL, Mergenhagen SE (1969) Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature 221:873
Hu B, Even C, Plagemann PGW (1991) Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a and IgG2b-specific polyclonal activation of B cells. Viral Immunol 5:27
Inada T, Mims CA (1985) Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Arch Virol 86:151
Inada T, Kikuchi H, Yamazaki S (1993) Comparison between lactate dehydrogenase-elevating virus and its virion-RNA on infection of murine leukemia virus-infected and -uninfected cell lines. J Virol 67:5698
Izakov N, Feldman M, Segal S (1982) Lactic dehydrogenase virus (LDV) impairs antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Immunology 162:15
Kelsoe G (1994) B cell diversification and differentiation in the periphery. J Exp Med 180:5
Koup RA (1994) Virus escape from CTL recognition. J Exp Med 180:779
Kowalchyk K, Plagemann PGW (1985) Cell surface receptors for lactate dehydrogenase-elevating virus on subpopulation of macrophages. Virus Res 2:211
Kuo L, Chen Z, Rowland RRR, Faaberg KS, Plagemann PGW (1992) Lactate dehydrogenase-elevating virus (LDV): subgenomic mRNAs, mRNA leader and comparison of 3′-terminal sequences of two LDV isolates. Virus Res 23:55
Li X, Hu B, Harty J, Even C, Plagemann PGW (1990) Polyclonal activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lymphocytes. Viral Immunol 3:273
MacClennan I (1991) The centre of hypermutation. Nature 354:352
Matzinger P (1994) Memories are made of this? Nature 369:605
Meredith MJ (1993) Porcine reproductive and respiratory syndrome, 7th edn. University of Cambridge Press, Cambridge
Meulenberg JJM, de Meijer EJ, Moormann RJM (1993) Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction sequence. J Gen Virol 74:1697
Meulenberg JJM, Hulst MM, de Meijer EJ, Moonen EJ, den Besten PLJM, de Cluyver A, Vensvoort EP, Moormann RJM (1993) Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV. Virology 192:62
Michaelides MC, Sims ES (1980) Immune response in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cell Immunol 50:253
Moskophidis D, Lechner F, Pircher P, Zinkernagel RM (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758
Murphy WH, Mazur JJ, Fulton SA (1987) Animal model for neuron disease. In: Behan WMH, Behan PO, Aarli JA (eds) Clinical neuroimmunology. Blackwell, Oxford, pp 135–155
Murtaugh M, Collins JE, Rossow KD (1993) Porcine respiratory and reproductive syndrome. In: Allen D. Leman Swine Conference. University of Minnesota Press, Minneapolis, pp43–53
Oldstone MBA (1989) Viral persistence. Cell 56:517
Onyekaba CO, Harty JT, Even C, Hu B, Plagemann PGW (1989) Persistent infection of mice by lactate dehydrogenase elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res 14:297
Onyekaba CO, Harty JT, Plagemann PGW (1989) Extensive cytocidal replication of lactate dehydrogenase-elevating virus in cultured peritoneal macrophages from 1 and 2-week-old mice. Virus Res 14:327
Palmer GA, Kuo L, Chen Z, Faaberg K, Plagemann PGW (1995) Sequence of genome of lactate dehydrogenase-elevating virus: heterogeneity between strains P and C. Virology 209:637
Plagemann PGW (1996) Lactate dehydrogenase-elevating virus and related viruses. In: Fields BN, Knipe DM, Howley DM (eds) Virology, 3rd edn. Raven Press, New York, pp 1105–1120
Plagemann PGW, Moennig V (1992) Lactate dehydrogenase-elevating virus, equine arteritis virus and simian hemorrhagic fever virus: a new group of positive stranded RNA viruses. Adv Virus Res 41:99
Plagemann PGW, Harty JT, Even C (1992) Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies. Arch Virol 123:89
Porter DD, Porter HG, Deerhake BB (1969) Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. J Immunol 102:431
Riley V, Braun W, Ishizuka M, Spackman D (1976) Antibody-producing cells: virus-induced alteration of response to antigen. Proc Natl Acad Sci USA 73:1707
Riley V, Lilly F, Huerto E, Bardell D (1960) Transmissible agent associated with 26 types of experimental mouse neoplasms. Science 132:545
Rowland RRR, Butz EA, Plagemann PGW (1994) Nitric oxide production by macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus. J Immunol 152:5785
Rowland RRR, Even C, Anderson GW, Chen Z, Hu B, Plagemann PGW (1994) Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viremia or the polyclonal activation of B cells and immune complex formation. J Gen Virol 75:1071
Rowland RRR, Anderson GW, Palmer GA, Even C, Plagemann PGW (1995) Lactate dehydrogenaseelevating virus replication persists in liver, spleen, lymph nodes and testis and results in accumulation of viral RNA in germinal centers concomitant with polyclonal activation of B cells. 69:5177
Rowson KEK, Mahy BWJ (1975) Lactic dehydrogenase virus. Virol Monogr 13
Rowson KEK, Many BWJ (1985) Lactate dehydrogenase-elevating virus. J Gen Virol 66:2297
Snijder EJ, Wassenaar ALM, Spaan WJM (1992) The 5′ end of the equine arteritis virus replicase gene encodes a papainlike cysteine protease. J Virol 66:7040
Snijder EJ, Wassenaar ALM, Spaan WJM (1994) Proteolytic processing of the replicase ORF 1a protein of equine arteritis virus. J Virol 68:5755
Stueckemann JA, Holth M, Swart WJ, Kowalchyk K, Smith MS, Wolstenholme AJ, Cafruny WA, Plagemann, PGW (1982) Replication of lactate dehydrogenase-elevating virus in macrophages. 2.Mechanism of persistent infection in mice and cell culture. J Gen Virol 59:263
Stueckemann JA, Ritzi D, Holth M, Smith MS, Swart WJ, Cafruny WA, Plagemann PGW (1982) Replication of lactate dehydrogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. J Gen Virol 59:245
Tong SL, Stueckemann JA, Plagemann PGW (1977) Autoradiographic method for detection of lactate dehydrogenase-elevating virus-infected cells in primary mouse macrophage culture. J Virol 22:219
Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117
Weiland E, Weiland F, Grossmann A (1987) Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies. J Gen Virol 68:1983
Williams MA, Lamb RA (1988) Polylactosaminoglycan modification of a small integral membrane glycoprotein, influenza B virus NB. Mol Cell Biol 8:1186
Zinkernagel RM, Moskophidis D, Kündig T, Oehen S, Percher H, Hengartner H (1993) Effector T cell induction and T cell memory versus peripheral deletion of T cells. Immunol Rev 131:199
Zinkernagel RM, Hengartner H (1994) T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 15:262